Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Aquestive Therapeutics Inc. (AQST)

4.29   -0.25 (-5.51%) 07-10 16:00
Open: 4.55 Pre. Close: 4.54
High: 4.55 Low: 4.2
Volume: 581,279 Market Cap: 144M
Aquestive Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery in the United States and internationally. Its proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.555 - 4.584 4.584 - 4.604
Low: 4.136 - 4.17 4.17 - 4.193
Close: 4.245 - 4.295 4.295 - 4.33

Technical analysis

as of: 2020-07-10 4:25:17 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 6.15     One year: 6.91
Support: Support1: 4.20    Support2: 3.49
Resistance: Resistance1: 5.26    Resistance2: 5.92
Pivot: 4.95
Moving Average: MA(5): 4.55     MA(20): 5.00
MA(100): 4.10     MA(250): 4.34
MACD: MACD(12,26): -0.17     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 8.73     %D(3): 8.19
RSI: RSI(14): 34.18
52-week: High: 10.00  Low: 1.41  Change(%): 3.4
Average Vol(K): 3-Month: 107870  10-Days: 85659

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
AQST has closed above bottom band by 8.1%. Bollinger Bands are 15.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 07 Jul 2020
What Type Of Shareholders Own The Most Number of Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares? - Simply Wall St

Mon, 06 Jul 2020
What Is The Ownership Structure Like For Aquestive Therapeutics, Inc. (NASDAQ:AQST)? - Yahoo Finance

Mon, 29 Jun 2020
Financial Insights and Technical Data on Aquestive Therapeutics, Inc. (AQST) - Invest Million

Mon, 29 Jun 2020
Aquestive Therapeutics Files IND for Pharmacokinetic Clinical Trials of AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Anaphylaxis Treatment - GlobeNewswire

Fri, 26 Jun 2020
Where Does Aquestive Therapeutics Inc (AQST) Stock Fall in the Biotechnology Field? - InvestorsObserver

Thu, 25 Jun 2020
Hedge Funds Aren’t Crazy About Aquestive Therapeutics, Inc. (AQST) Anymore - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 34
Shares Float (M) 28
% Held by Insiders 13.68
% Held by Institutions 57.50
Shares Short (K) 1,630
Shares Short P. Month (K) 1,390

Stock Financials

EPS -2.470
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.620
Profit Margin -139.64
Operating Margin -109.69
Return on Assets (ttm) -50.4
Return on Equity (ttm)
Qtrly Rev. Growth -30.7
Gross Profit (p.s.) 0.960
Sales Per Share 1.451
EBITDA (p.s.) -1.498
Qtrly Earnings Growth
Operating Cash Flow (M) -56
Levered Free Cash Flow (M) -35

Stock Valuations

PE Ratio -1.74
PEG Ratio
Price to Book value -6.92
Price to Sales 2.96
Price to Cash Flow -2.56

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.